Press release
Pneumococcal Vaccine Market 2023 - Trends, Size, Share, Growth Status And Forecast 2032
Pneumococcal Vaccine Market
The Business Research Company's Pneumococcal Vaccine Global Market Report 2023 identifies increasing prevalence of pneumococcal contamination as the major driver for the Pneumococcal Vaccine market's growth in the forecast period. Pneumococcal contamination refers to any infection caused by bacteria called Streptococcus pneumoniae or pneumococcus, such as pneumonia, bloodstream infections, ear infections, and sinus infections.
The global pneumococcal vaccine market size is expected to grow from $7.92 billion in 2022 to $8.47 billion in 2023 at a compound annual growth rate (CAGR) of 6.9%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The size of pneumococcal vaccine market is expected to reach $10.66 billion in 2027 at a CAGR of 5.9%.
Download Free Sample Of Pneumococcal Vaccine Market Report - https://www.thebusinessresearchcompany.com/sample.aspx?id=11950&type=smp
Major competitors in the Pneumococcal Vaccine market are Pfizer Inc., Johnson & Johnson, Merck & Co. Inc., Novartis International AG, Sanofi S.A., AstraZeneca plc.
A key trend in the Pneumococcal Vaccine market includes product innovations. Major companies operating in the pneumococcal vaccine market are developing new products with unique features to sustain their position in the market. For instance, in December 2020, Serum Institute of India Pvt. Ltd., an India-based vaccine manufacturer, launched PNEUMOSIL to fight against pneumococcal pneumonia among children. PNEUMOSIL (Pneumococcal Conjugate Vaccine - Adsorbed, 10 Valent) is a well-designed vaccine with relevant serotypes that is less expensive than existing PCVs and provides equivalent protection by targeting the most common serotypes of the bacterium that causes significant illness.
Read More On The Global Pneumococcal Vaccine Market Report Here:
https://www.thebusinessresearchcompany.com/report/pneumococcal-vaccine-global-market-report
The Pneumococcal Vaccine market is segmented -
• By Product Type: Prevnar 13, Synflorix, Pneumovax23, Other Products
• By Route of Administration: Intravenous, Intramuscular, Subcutaneous
• By Distribution Channel: Pharmacies, Community Clinics, Public Health Agencies, Other Distribution Channels
• By End User: Pediatrics, Adults
• By Geography: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. North America was the largest region in the Pneumococcal Vaccine market.
The Business Research Company's "Global Pneumococcal Vaccine Market Report 2023" provides a thorough understanding of the market across 60 geographies. The report covers market size, growth rate, segments, drivers and trends in every region and country. In addition, the report offers insights on historical and forecast growth, helping players analyze and strategize better.
Explore Buying Options For The Pneumococcal Vaccine Market Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=11950
The Table Of Content For The Pneumococcal Vaccine Market Include:
1. Executive Summary
2. Pneumococcal Vaccine Market Characteristics
3. Pneumococcal Vaccine Market Trends And Strategies
4. Pneumococcal Vaccine Market - Macro Economic Scenario
5. Global Pneumococcal Vaccine Historic Market Size and Growth, 2017 - 2022, Value ($ Billion)
……………………………………….
32. Global Pneumococcal Vaccine Market Competitive Benchmarking
33. Global Pneumococcal Vaccine Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Pneumococcal Vaccine Market
35. Pneumococcal Vaccine Market Future Outlook and Potential Analysis
36. Appendix
Contact us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Latest Trending Press Releases: https://www.thebusinessresearchcompany.com/press-release.aspx
Want To Know More About The Business Research Company?
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.
Global Market Model - World's Most Comprehensive Database
The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Pneumococcal Vaccine Market 2023 - Trends, Size, Share, Growth Status And Forecast 2032 here
News-ID: 3218084 • Views: …
More Releases from The Business research company
Ventricular Assist Device Industry Outlook 2025-2029: Market Set to Cross $3.87 …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Ventricular Assist Device Market Size By 2025?
The market size of the ventricular assist device has seen rapid expansion in recent years. A growth from $2.12 billion in 2024 to $2.37 billion in 2025 is projected, reflecting a compound annual growth rate (CAGR) of 11.8%.…
Key Trends Reshaping the Sunglasses Market: Leading Sunglass Brands Embrace AI W …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Sunglasses Market Size Growth Forecast: What to Expect by 2025?
In recent times, the market size of sunglasses has been on a progressive rise. It is projected to increase from $18.11 billion in 2024 to an estimated $18.93 billion in 2025, experiencing a compound annual growth rate (CAGR) of…
Advanced Diagnostics And Treatments Drive Demand For PTA Balloon Catheters: A Ke …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
PTA Balloon Catheter Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
In the recent past, the market size for pta balloon catheter has seen substantial growth. The projections reveal that the growth scale will go up from $2.33 billion in 2024 to $2.56 billion in…
Soaring Demand Set to Propel Nuclear Medicine Diagnostics Market to $12.38 Billi …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Nuclear Medicine Diagnostics Market Through 2025?
In recent years, the nuclear medicine diagnostics market has seen a quick expansion. The market's size will increase from $7.16 billion in 2024 to $7.88 billion in 2025 at a compound annual growth rate (CAGR) of…
More Releases for Pneumococcal
Invasive Pneumococcal Disease Market Massive Growth opportunity Ahead
Introduction
Invasive pneumococcal disease (IPD), caused by Streptococcus pneumoniae, remains one of the leading causes of serious illness and death worldwide. Manifesting as meningitis, bacteremia, and severe pneumonia, IPD poses the greatest risk to infants, elderly adults, and immunocompromised patients. Despite progress in immunization, the disease continues to cause a significant global burden, particularly in regions with limited vaccine access.
The Invasive Pneumococcal Disease Market is entering a transformative phase, fueled by…
Key Influencer in the Pneumococcal Vaccine Market 2025: Rising Prevalence Of Pne …
What combination of drivers is leading to accelerated growth in the pneumococcal vaccine market?
The escalating occurrence of pneumococcal infections is projected to boost the pneumococcal vaccine market's growth. Pneumococcal infections represent any condition triggered by the bacterium Streptococcus pneumoniae, also known as pneumococcus. This includes illnesses like pneumonia, bloodstream infections, ear infections, and sinus infections. The pneumococcal vaccine encourages the body to generate antibodies against these bacteria, thereby minimizing or…
Pneumococcal Vaccines Market - Preventing Pneumonia: Safeguarding Health with Pn …
Newark, New Castle, USA: The "Pneumococcal Vaccines Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Pneumococcal Vaccines Market: https://www.growthplusreports.com/report/pneumococcal-vaccines-market/7761
This latest report researches the industry structure, sales, revenue,…
Global To Invigorate The Intravenous Pneumococcal Vaccines Market
Pneumococcal vaccine is used to prevent infection caused by streptococcus pneumoniae bacteria. There are two types of pneumococcal vaccines: pneumococcal conjugate vaccine and pneumococcal polysaccharide vaccine.
The Centers for Disease Control and Prevention (CDC) recommends pneumococcal conjugate vaccine for all children younger than two years of age, all adults 65 years or older, and for people 2-64 years old with certain medical conditions. The CDC recommends pneumococcal polysaccharide vaccine for all…
Pneumococcal Vaccines Market Demands and Gross Margin 2027
"Industry analysis is a crucial step in the current competitive market space that helps identify the right target customers and accordingly provide tailored solutions for their business needs. Every aspect and unique challenges put up by the particular industry are carefully taken into consideration while formulating these solutions. It also takes into consideration various government reforms, competitive environment, customer behavior, existing and upcoming business models, and ever-evolving technological developments. Industry…
Pneumococcal Vaccine Report on Global Pneumococcal Vaccine Market Development, p …
Latest Survey on Pneumococcal Vaccine Market:
The Global Pneumococcal Vaccine market report value has been estimated considering the application and regional segments, market share, and size, while the forecast for each product type and application segment has been provided for the global markets. The Pneumococcal Vaccine report offers detailed profiles of the key players to bring out a clear view of the competitive landscape of the Pneumococcal Vaccine Outlook. It also…
